T Cells & B Cells — T cells and B cells (overview) - Microbiology

SECTION 1

Historical Context & Motivation

The modern understanding of adaptive immunity rests upon a century of experiments that gradually revealed the existence of two distinct lymphocyte lineages. Before scientists identified T cells and B cells, the prevailing view held that white blood cells were a relatively homogeneous population that combatted infection through phagocytosis alone. The discovery that lymphocytes could be divided into functionally and developmentally separate compartments—one responsible for cell-mediated immunity and the other for humoral immunity—transformed immunology from a descriptive discipline into a mechanistic science with profound clinical implications.

1956 • Role of the Thymus Discovered

Jacques Miller demonstrated through neonatal thymectomy in mice that the thymus is essential for immune competence, providing the first evidence that a central lymphoid organ governs a distinct lymphocyte population.

1965 • T and B Cell Dichotomy Established

Work by Miller, Mitchell, and others in avian systems (using the bursa of Fabricius) established that two separate lineages—thymus-derived (T) and bursa-derived (B) lymphocytes—collaborate to mount effective immune responses.

1974 • MHC Restriction Revealed

Zinkernagel and Doherty showed that cytotoxic T cells recognize antigen only in the context of self-MHC molecules, a landmark finding that earned the 1996 Nobel Prize and explained T cell specificity at the molecular level.

1975 • Monoclonal Antibody Technology

Köhler and Milstein developed hybridoma technology to produce monoclonal antibodies, exploiting the antibody-secreting capacity of B cells and opening the door to targeted immunotherapies and diagnostics.

1987 • T Cell Receptor Gene Cloned

The complete characterization of the T cell receptor (TCR) genes by Tonegawa and collaborators confirmed that T cells use a recombination mechanism analogous to immunoglobulin gene rearrangement, unifying the molecular logic of adaptive immunity.

These discoveries raised a central question that continues to drive immunological research: how do T cells and B cells, arising from the same hematopoietic stem cell, diverge so dramatically in their receptor systems, effector functions, and regulatory roles—and how does their cooperation generate the specificity, diversity, and immunological memory that define adaptive immunity?

SECTION 2

Core Principles & Definitions

Both T cells and B cells are lymphocytes—a category of white blood cell that participates in the adaptive arm of the immune system. Despite sharing a common origin in the bone marrow's hematopoietic stem cells, these two populations differentiate in distinct anatomical compartments, express unique antigen receptors, and execute complementary effector programs. Understanding their shared and divergent properties requires grasping several foundational principles.

Clonal Selection

Each lymphocyte bears a unique receptor. When antigen engages that receptor, the cell is selected and proliferates into a clone of effector and memory cells—ensuring a pathogen-specific response.

Antigen Receptor Diversity

V(D)J recombination shuffles variable (V), diversity (D), and joining (J) gene segments during lymphocyte development, generating an estimated 10¹⁵–10¹⁸ possible receptor specificities for T and B cells combined.

Self-Tolerance

During maturation in the thymus (T cells) or bone marrow (B cells), lymphocytes that strongly recognize self-antigens are eliminated or silenced through central tolerance mechanisms, minimizing autoimmune pathology.

Immunological Memory

After antigen clearance, a subset of activated lymphocytes persists as long-lived memory cells, mounting faster and stronger secondary responses upon re-exposure—the basis of vaccination.

T–B Cooperation

Most B cell responses to protein antigens require cognate help from T helper cells, delivered via MHC class II presentation, co-stimulatory molecules (CD40–CD40L), and cytokines—linking the two arms of adaptive immunity.

✦

KEY TAKEAWAY

Think of T cells and B cells as two specialized divisions of a security force. B cells are the artillery—they manufacture and launch antibodies (projectiles) that neutralize threats at a distance in blood and mucosal surfaces. T cells are the special operations teams—they patrol tissues, directly inspect each cell's 'identification badge' (MHC–peptide complex), and eliminate compromised cells or coordinate the broader response. Neither division alone is sufficient; effective defense demands their collaboration.

SECTION 3

Visual Overview — Lymphocyte Development & Function

_{(Helper)CD8⁺ T(Cytotoxic)Mature B Cell(Naïve)Cytokine SecretionIL-2, IFN-γ, IL-4, IL-17Target Cell KillingPerforin / GranzymesPlasma CellSecretes AntibodiesMemory B CellLong-lived recallT cell helpHSC = Hematopoietic Stem Cell; CD = Cluster of Differentiation}

Both T and B cells arise from the same hematopoietic stem cell (top). Progenitors destined to become T cells migrate to the thymus (left branch), where positive and negative selection yield CD4⁺ helper and CD8⁺ cytotoxic subsets. B cell progenitors mature within the bone marrow (right branch) and, upon antigen encounter and T cell help, differentiate into antibody-secreting plasma cells or long-lived memory B cells.

The diagram above encapsulates the central organizational logic of adaptive immunity. Notice that the divergence point is anatomical: the thymus sculpts T cell repertoires through a stringent two-stage selection process, while the bone marrow accomplishes an analogous screening for B cells. The dashed line between T helper cells and the B cell branch represents the critical cognate interaction—most B cell responses to protein antigens are T-dependent, meaning class switching and affinity maturation require signals delivered by CD4⁺ T cells in germinal centers.

SECTION 4

Mechanisms of Antigen Recognition

The most fundamental distinction between T cells and B cells lies in how they recognize antigen. B cells express the B cell receptor (BCR), which is a membrane-bound immunoglobulin capable of binding intact, native antigen—proteins, carbohydrates, lipids, and even small chemical haptens—in three-dimensional conformation. T cells, on the other hand, express the T cell receptor (TCR), which can only recognize short peptide fragments presented in the groove of major histocompatibility complex (MHC) molecules on the surface of antigen-presenting cells or target cells. This MHC restriction is the hallmark of T cell biology.

BCR vs. TCR Structure

The BCR consists of a membrane-bound immunoglobulin (mIg) molecule—typically IgM or IgD on naïve B cells—non-covalently associated with the signaling heterodimer Igα/Igβ (CD79a/CD79b). The mIg provides antigen specificity through its variable regions (V_H and V_L), while Igα/Igβ contain immunoreceptor tyrosine-based activation motifs (ITAMs) that transduce signals into the cell upon antigen crosslinking. The TCR, by contrast, is a heterodimer of α and β chains (or γ and δ chains in a minor subset), each containing one variable and one constant domain. Like the BCR, the TCR relies on associated signaling modules—the CD3 complex (γε, δε, and ζζ dimers)—to initiate intracellular signaling cascades through their ITAMs.

MHC Class I vs. Class II Restriction

The co-receptor expressed by a T cell determines which class of MHC molecule it surveys. CD8⁺ cytotoxic T lymphocytes (CTLs) recognize peptides presented by MHC class I molecules, which are expressed on nearly all nucleated cells and typically present endogenously synthesized peptides—including viral proteins and tumor antigens. CD4⁺ T helper (T_H) cells recognize peptides displayed by MHC class II molecules, which have a more restricted tissue distribution—primarily expressed on professional antigen-presenting cells such as dendritic cells, macrophages, and B cells—and present exogenous, phagocytosed antigens.

Side-by-side comparison of the three principal antigen recognition modes. CD8⁺ T cells bind endogenous peptides (8–10 amino acids) on MHC class I; CD4⁺ T cells bind exogenous peptides (13–25 amino acids) on MHC class II; and B cells bind intact, native antigen directly through the BCR without MHC involvement.

⚠

Critical Distinction

T cells require antigen processing—proteins must be degraded into peptides and loaded onto MHC molecules before T cells can respond. B cells can recognize native, unprocessed antigen in its intact three-dimensional form. This difference underpins the complementary roles: B cell antibodies can neutralize extracellular pathogens and toxins in their native state, while T cells survey the intracellular proteome via MHC display.

SECTION 5

T Cell and B Cell Subsets in Detail

The terms 'T cell' and 'B cell' each encompass a family of functionally distinct subsets. Appreciating this diversity is essential because different subsets are activated by different cytokine milieus, express different transcription factors, and execute different effector programs. Clinical pathologies—from immunodeficiencies to autoimmune diseases—often map to the dysfunction of a specific subset rather than a wholesale failure of an entire lineage.

Major T Cell Subsets

Subset	Key Markers	Master TF	Signature Cytokines	Primary Function
Tₕ1	CD4⁺, CXCR3	T-bet	IFN-γ, TNF-α	Activates macrophages; intracellular pathogen defense
Tₕ2	CD4⁺, CCR4	GATA-3	IL-4, IL-5, IL-13	Drives B cell class switching to IgE; anti-helminth
Tₕ17	CD4⁺, CCR6	RORγt	IL-17A, IL-22	Neutrophil recruitment; mucosal barrier defense
Tₕfollicular	CD4⁺, CXCR5, PD-1	Bcl-6	IL-21, IL-4	Germinal center B cell help; affinity maturation
T_reg	CD4⁺, CD25⁺, FoxP3⁺	FoxP3	IL-10, TGF-β	Suppresses immune responses; maintains self-tolerance
CTL (CD8⁺)	CD8⁺, Granzyme B	T-bet / Eomes	IFN-γ, TNF-α	Direct killing of virus-infected and tumor cells

TF = transcription factor

Major B Cell Subsets

Subset	Location	Key Features	Ig Isotype
Follicular (FO) B	Lymph node follicles, spleen	T-dependent responses; undergo germinal center reactions, somatic hypermutation, class switching	IgM → IgG, IgA, IgE
Marginal Zone (MZ) B	Splenic marginal zone	T-independent responses to blood-borne polysaccharides; rapid IgM secretion	Primarily IgM
B-1 B	Peritoneal and pleural cavities	Produce natural antibodies; innate-like; self-renewing	IgM (natural antibodies)
Plasma Cell	Bone marrow, mucosal sites	Terminally differentiated; high-rate antibody secretion (~2000 molecules/sec per cell)	IgG, IgA, IgM, IgE
Memory B	Circulation, secondary lymphoid organs	Long-lived; rapid differentiation to plasma cells upon re-exposure; somatically mutated high-affinity BCR	Class-switched

ℹ

Clinical Connection

T_reg dysfunction is implicated in autoimmune diseases such as type 1 diabetes and IPEX syndrome (a FoxP3 mutation). Conversely, excessive T_reg activity in the tumor microenvironment suppresses anti-tumor CTL responses—making T_reg depletion a strategy in cancer immunotherapy.

SECTION 6

Worked Example — Tracing an Immune Response

To integrate T cell and B cell biology, let us trace the adaptive immune response to a hypothetical intramuscular injection of an inactivated influenza vaccine containing hemagglutinin (HA) protein antigen.

Adaptive Immune Response to Influenza Vaccination

1
Step 1 — Antigen Capture and Processing

Dendritic cells (DCs) at the injection site phagocytose the HA protein. Within endosomal compartments, HA is degraded into peptide fragments of approximately 13–25 amino acids. These peptides are loaded onto MHC class II molecules and transported to the DC surface. Simultaneously, the DC upregulates co-stimulatory molecules (B7-1/B7-2) and migrates via afferent lymphatics to the draining lymph node.

MHC II–peptide complexes displayed on mature DCs in the T cell zone of the lymph node.
2
Step 2 — CD4⁺ T Cell Priming

Naïve CD4⁺ T cells circulating through the lymph node scan DCs for cognate MHC II–peptide complexes via their TCRs. A T cell whose TCR matches the HA-derived peptide engages in a stable immunological synapse. Signal 1 (TCR–MHC II–peptide) plus Signal 2 (CD28–B7 co-stimulation) plus Signal 3 (polarizing cytokines such as IL-12) drives the T cell to proliferate and differentiate into effector T_H1 cells (producing IFN-γ) and T_FH cells that migrate toward the B cell follicle.

Clonal expansion of HA-specific CD4⁺ T cells; generation of T_FH cells.
3
Step 3 — B Cell Activation and T–B Cooperation

A naïve follicular B cell whose BCR recognizes a conformational epitope on intact HA protein internalizes the antigen via receptor-mediated endocytosis, processes it, and presents HA-derived peptides on its own MHC class II. At the T–B border, a cognate T_FH cell recognizes the same peptide–MHC II complex and provides help: CD40L on the T cell engages CD40 on the B cell, and the T_FH secretes IL-21 and IL-4.

Linked recognition ensures that only B cells presenting the correct peptide receive T cell help—this is the basis of T-dependent B cell activation.
4
Step 4 — Germinal Center Reaction

The activated B cell enters a germinal center, where it undergoes rapid proliferation, somatic hypermutation (SHM) of its immunoglobulin variable region genes, and selection for higher-affinity variants by follicular dendritic cells displaying antigen–antibody complexes. Concurrently, class-switch recombination (CSR) directed by T_FH-derived cytokines converts the antibody isotype from IgM to IgG (or IgA at mucosal sites).

Output: high-affinity, class-switched plasma cells secreting anti-HA IgG, and long-lived memory B cells.
5
Step 5 — Effector Phase and Memory

Secreted anti-HA IgG antibodies circulate systemically, providing protection through viral neutralization (blocking HA binding to host cell sialic acid receptors), opsonization, and complement activation. Memory T_H cells and memory B cells persist in secondary lymphoid organs and circulation. Upon subsequent influenza infection, memory cells mount a faster, higher-magnitude secondary response with predominantly high-affinity IgG—the protective principle underlying vaccination.

Immunological memory established; secondary response upon natural infection is rapid and robust.

SECTION 7

T Cells vs. B Cells — Side-by-Side Comparison

While T cells and B cells are both lymphocytes with somatically rearranged antigen receptors, their differences in development, receptor structure, antigen recognition, and effector output are profound. The following table consolidates the major distinguishing features to serve as a reference for comparison.

Feature	T Cells	B Cells
Site of maturation	Thymus	Bone marrow
Antigen receptor	TCR (αβ or γδ heterodimer)	BCR (membrane-bound Ig)
Antigen form recognized	Processed peptide on MHC	Native (intact) antigen
MHC restriction	Yes (MHC I for CD8⁺; MHC II for CD4⁺)	No
Somatic hypermutation	No (TCR affinity is fixed after thymic selection)	Yes (occurs in germinal centers)
Secreted receptor form	No (TCR is not secreted)	Yes (antibodies = secreted Ig)
Primary effector outputs	Cytokine secretion (Tₕ); cytotoxic killing (CTL); immune suppression (Treg)	Antibody secretion (plasma cells); antigen presentation to T cells
Surface markers	CD3 (all T); CD4 (helper); CD8 (cytotoxic)	CD19, CD20, surface Ig
Class switching	Not applicable	Yes (IgM → IgG, IgA, IgE)

Key differences between T and B lymphocytes

✦

KEY TAKEAWAY

The T cell–B cell dichotomy represents a division of labor evolved to handle the full spectrum of microbial threats. B cells and their secreted antibodies excel at neutralizing extracellular pathogens—bacteria, free viruses, and toxins circulating in body fluids. T cells excel at dealing with intracellular threats that antibodies cannot reach: CD8⁺ CTLs eliminate virus-infected and tumor cells, while CD4⁺ T helper cells orchestrate the type and magnitude of the overall response. Immune competence depends on both arms functioning and cooperating.

SECTION 8

Connection to Advanced Immunology

The overview of T and B cell biology presented here serves as a foundation for several advanced topics that are the focus of current immunological research and clinical translation. Understanding these connections provides a roadmap for deeper study.

Foundational Concept (This Lesson)	Advanced Extension	Clinical / Research Relevance
CD8⁺ CTL recognition via MHC I	Immune checkpoint pathways (PD-1/PD-L1, CTLA-4)	Checkpoint inhibitor immunotherapy for cancer (e.g., pembrolizumab, nivolumab)
Tₕ subset differentiation	Plasticity of CD4⁺ subsets; trans-differentiation under cytokine pressure	Targeting Tₕ17/Treg balance in autoimmune diseases (e.g., IL-17 inhibitors for psoriasis)
T–B cooperation and germinal centers	Broadly neutralizing antibody (bnAb) development; affinity maturation kinetics	Rational vaccine design for HIV, influenza, SARS-CoV-2 variants
BCR signaling via ITAMs	B cell lymphoma oncogenesis; tonic BCR signaling	Bruton's tyrosine kinase (BTK) inhibitors (ibrutinib) for CLL
Clonal selection and memory	CAR-T cell engineering; chimeric antigen receptors that bypass MHC restriction	CAR-T therapy for B cell malignancies (CD19-directed)

From foundational to advanced immunology

One of the most transformative clinical applications arising from T and B cell biology is CAR-T cell therapy, in which a patient's own T cells are genetically engineered ex vivo to express a chimeric antigen receptor—typically an antibody-derived single-chain variable fragment (scFv) fused to intracellular T cell signaling domains. This construct effectively gives a T cell the antigen-binding specificity of an antibody (B cell heritage) combined with the cytotoxic machinery of a CTL (T cell heritage), creating a hybrid weapon that bypasses the need for MHC presentation entirely. Success in treating relapsed B cell acute lymphoblastic leukemia highlights how a deep understanding of both lineages enables innovative therapeutic design.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

Explain why T cells are described as 'MHC-restricted' while B cells are not. What structural and functional consequence does this distinction have for the types of antigens each lineage can recognize?

Show answer

T cells are MHC-restricted because the TCR recognizes a composite ligand formed by a peptide fragment sitting in the groove of an MHC molecule. Without MHC presentation, T cells cannot 'see' antigen—this is because the TCR co-evolved with MHC and contacts both the peptide and the MHC α-helices flanking the groove. B cells, in contrast, use their BCR (membrane-bound immunoglobulin) to bind intact, three-dimensional epitopes directly—no processing or MHC presentation is required. As a consequence, T cells are restricted to protein-derived peptide antigens (since only proteins are efficiently processed into peptides and loaded onto MHC), while B cells can recognize proteins, carbohydrates, lipids, nucleic acids, and even small chemical haptens in their native conformation.

Question 2: BASIC CALCULATION

A single long-lived plasma cell secretes approximately 2,000 antibody molecules per second. Estimate the total number of antibody molecules a single plasma cell produces over a 30-day period. Express your answer in scientific notation.

Show answer

First, convert 30 days to seconds: 30 days × 24 hours/day × 60 min/hour × 60 sec/min = 2,592,000 seconds ≈ 2.59 × 10⁶ seconds. Then multiply by the secretion rate: 2,000 molecules/sec × 2.59 × 10⁶ sec ≈ 5.18 × 10⁹ antibody molecules. This remarkable output—over 5 billion antibodies from a single cell in one month—illustrates why even a modest number of plasma cells can flood the serum with protective immunoglobulin during an immune response. Long-lived plasma cells in the bone marrow can survive for decades, contributing to sustained serological memory.

Question 3: INTERMEDIATE

A patient with DiGeorge syndrome (thymic aplasia) has a profound deficiency of T cells but initially normal B cell numbers. Predict the consequences for both cell-mediated and humoral immunity, and explain why humoral responses to protein antigens would be impaired even though B cells are present.

Show answer

Without a functional thymus, T cell precursors cannot undergo positive and negative selection, resulting in a severe deficiency of both CD4⁺ and CD8⁺ T cells. Cell-mediated immunity is directly abolished: the patient cannot mount CTL responses against virus-infected cells or activate macrophages via Tₕ1-derived IFN-γ. Humoral immunity to protein (T-dependent) antigens is also profoundly impaired because B cell activation, germinal center formation, somatic hypermutation, and class switching all require cognate help from CD4⁺ T follicular helper cells delivered through CD40L–CD40 interactions and cytokines like IL-21. Although B cells are present, they cannot progress beyond an initial low-affinity IgM response without T cell help. Responses to T-independent antigens (e.g., bacterial polysaccharides recognized by marginal zone B cells) may be partially preserved, though overall antibody quality and memory are severely compromised.

Question 4: APPLIED

An immunologist is designing a subunit vaccine against a novel bacterial toxin. She must decide between using the purified polysaccharide capsule alone versus a conjugate vaccine linking the polysaccharide to a carrier protein. Using your knowledge of T–B cooperation, explain why the conjugate strategy would likely produce a stronger and longer-lasting antibody response.

Show answer

Polysaccharides are T-independent antigens: they can crosslink BCRs on marginal zone and B-1 B cells and elicit a primary IgM response, but they do not generate peptides that can be loaded onto MHC class II for presentation to CD4⁺ T helper cells. Without T cell help, there is no germinal center reaction, minimal somatic hypermutation (so no affinity maturation), limited class switching (antibodies remain predominantly IgM), and poor immunological memory. By conjugating the polysaccharide to a carrier protein, B cells that internalize the polysaccharide–protein complex via their anti-polysaccharide BCR can process and present carrier-derived peptides on MHC class II. This recruits T follicular helper cells, which provide CD40L co-stimulation and IL-21, enabling germinal center formation, class switching to IgG, affinity maturation, and generation of long-lived memory B cells and plasma cells. This is exactly the strategy used in the Haemophilus influenzae type b (Hib) and pneumococcal conjugate vaccines, which dramatically improved efficacy in infants compared to plain polysaccharide formulations.

Question 5: CRITICAL THINKING

CAR-T cells targeting CD19 have shown remarkable success against B cell malignancies, but a major consequence is B cell aplasia (loss of all normal B cells). Analyze why this occurs, what immunological deficits result, and propose a strategy to mitigate those deficits while maintaining the anti-tumor effect.

Show answer

CD19 is expressed on virtually all B lineage cells from the pro-B cell stage through mature B cells, though it is absent from terminally differentiated plasma cells. CAR-T cells targeting CD19 cannot distinguish malignant from normal B cells because both express the target antigen; consequently, all CD19⁺ cells are destroyed, resulting in B cell aplasia. This leads to hypogammaglobulinemia—low serum IgG, IgA, and IgM—since the pool of B cells that would replenish short-lived plasma cells is eliminated (though pre-existing long-lived plasma cells lacking CD19 may persist temporarily). The patient becomes susceptible to encapsulated bacterial infections and other pathogens normally controlled by humoral immunity. The standard mitigation strategy is intravenous immunoglobulin (IVIG) replacement therapy, which provides passive antibody protection. More sophisticated approaches under investigation include engineering CAR-T cells with 'suicide switches' (e.g., inducible caspase-9) that allow clinicians to eliminate the CAR-T cells after tumor clearance to permit B cell reconstitution, or developing bispecific CARs targeting tumor-specific antigens (e.g., mutated surface proteins) rather than pan-B cell markers, thereby sparing normal B cells.

SUMMARY

Lesson Summary

Summary

T cells and B cells are the two principal lymphocyte lineages of adaptive immunity, both arising from hematopoietic stem cells in the bone marrow but maturing in different anatomical compartments—T cells in the thymus and B cells in the bone marrow. T cells express the TCR and recognize processed peptide antigens presented by MHC molecules, while B cells express the BCR (membrane-bound immunoglobulin) and recognize intact, native antigens without MHC restriction.

Key T cell subsets include CD4⁺ T helper cells (Tₕ1, Tₕ2, Tₕ17, T_FH), CD8⁺ cytotoxic T cells, and regulatory T cells (Treg). B cell subsets include follicular B cells, marginal zone B cells, and terminally differentiated plasma cells that secrete antibodies. The cooperation between T_FH cells and B cells in germinal centers drives somatic hypermutation, class-switch recombination, and the generation of immunological memory—processes that underpin effective vaccination and long-term protective immunity.